Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT

Fikri AS 1 , Kroiss A 2 , Ahmad AZ 3 , Zanariah H 4 , Lau WF 5 , Uprimny C 2 Show all authors , Donnemiller E 2 , Kendler D 2 , Nordin AJ 3 , Virgolini IJ 2

Affiliations 

  • 1 Centre for Diagnostic Nuclear Imaging, Faculty of Medicine and Health Science, University Putra Malaysia, Serdang, Selangor, Malaysia ahmadsaadff@gmail.com
  • 2 Univ.-KlinikfürNuklearmedizin, Innsbruck, Austria
  • 3 Centre for Diagnostic Nuclear Imaging, Faculty of Medicine and Health Science, University Putra Malaysia, Serdang, Selangor, Malaysia
  • 4 Medical Department, Hospital Putrajaya, Putrajaya, Malaysia
  • 5 Department of Radiology, the University of Melbourne, Centre for Molecular Imaging, The Peter MacCallum, Cancer Centre, East Melbourne, Victoria, Australia
Acta Radiol, 2014 Jun;55(5):631-40.
PMID: 24037430 DOI: 10.1177/0284185113504330

Abstract

To our knowledge, data are lacking on the role of 18F-FDG PET/CT in the localization and prediction of neuroendocrine tumors, in particular the pheochromocytoma/paraganglioma (PCC/PGL) group.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications